PROOF OF THE INVOLVEMENT OF PAF-ACETHER IN PULMONARY COMPLEX IMMUNE SYSTEMS USING A SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST - BN 52021

被引：1
作者：
TOUVAY, C [1 ]
VILAIN, B [1 ]
ETIENNE, A [1 ]
CLOSTRE, F [1 ]
DRIEU, K [1 ]
BRAQUET, P [1 ]
机构：
[1] IHB,RES LABS,F-92350 PLESSIS ROBINSON,FRANCE
来源：
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1985年 / 7卷 / 03期
关键词：
D O I：
10.1016/0192-0561(85)90412-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [21] A SYNTHETIC PSEUDOLIGNAN DERIVATIVE AS POTENT AND SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST
    HWANG, SB
    BIFTU, T
    DOEBBER, TW
    LAM, MHT
    WU, MS
    SHEN, TY
    PROSTAGLANDINS, 1985, 30 (04): : 689 - 689
  • [22] INTERACTION OF BN-52021 AND PAF-ACETHER WITH MEMBRANE ION-TRANSPORT
    GARAY, R
    DUNHAM, B
    ROSATI, C
    NAZARET, C
    BRAQUET, P
    PROSTAGLANDINS, 1985, 30 (04): : 712 - 712
  • [23] EFFECT OF BN-52021, A SPECIFIC ANTAGONIST OF PLATELET-ACTIVATING-FACTOR (PAF-ACETHER), ON CALCIUM MOVEMENTS AND PHOSPHATIDIC-ACID PRODUCTION INDUCED BY PAF-ACETHER IN HUMAN-PLATELETS
    SIMON, MF
    CHAP, H
    BRAQUET, P
    DOUSTEBLAZY, L
    THROMBOSIS RESEARCH, 1987, 45 (04) : 299 - 309
  • [24] THE INVOLVEMENT OF PAF-ACETHER IN ARTERIAL INVIVO THROMBOSIS
    BOURGAIN, RH
    ANDRIES, R
    MAES, L
    BRAQUET, P
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 303 - 303
  • [25] PAF-ACETHER CHEMOTACTIC ACTIVITY ON NEUTROPHILS IN BRONCHIAL-ASTHMA - EFFECT OF SPECIFIC PAF-ACETHER ANTAGONISTS
    RABIER, M
    DAMON, M
    HUERTA, JMM
    BRAQUET, P
    MICHEL, FB
    GODARD, P
    PROSTAGLANDINS, 1988, 35 (05): : 795 - 795
  • [26] BN 52021 AND RELATED-COMPOUNDS - A NEW SERIES OF HIGHLY SPECIFIC PAF-ACETHER RECEPTOR ANTAGONISTS - EFFECTS ON PAF-ACETHER-INDUCED PLATELET-AGGREGATION
    BRAQUET, PG
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 : 162 - 162
  • [27] INFLUENCE OF THE SPECIFIC ANTAGONIST OF PAF-ACETHER, BN-52021, AND OF GINKGO EXTRACT ON THE REJECTION OF MURINE TAIL SKIN ALLOGRAFTS AND THE PAF-ACETHER MORTALITY IN MICE IN PARTICULAR CONSIDERATION OF THE ROLE OF TXB2
    BECKER, K
    BRAQUET, P
    FORSTER, W
    BIOMEDICA BIOCHIMICA ACTA, 1988, 47 (10-11) : S165 - S168
  • [28] THE EFFECT OF PAF-ACETHER ANTAGONIST (BN-52021) ON CYCLOSPORINE (CSA) NEPHROTOXICITY - GLOMERULAR HEMODYNAMIC EVALUATION
    SANTOS, OFP
    BOIM, MA
    BREGMAN, R
    DRAIBE, SA
    SCHOR, N
    PROSTAGLANDINS, 1988, 35 (05): : 811 - 811
  • [29] PHARMACOLOGICAL CONTROL OF THE INVIVO PASSIVE ANAPHYLACTIC SHOCK BY THE PAF-ACETHER ANTAGONIST COMPOUND BN-52021
    VILAIN, B
    LAGENTE, V
    TOUVAY, C
    DESQUAND, S
    RANDON, J
    LEFORT, J
    BRAQUET, P
    VARGAFTIG, BB
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 : 119 - 126
  • [30] INTERFERENCE OF THE PAF-ACETHER ANTAGONIST BN 52021 WITH ENDOTOXIN-INDUCED HYPOTENSION IN THE GUINEA-PIG
    ADNOT, S
    LEFORT, J
    BRAQUET, P
    VARGAFTIG, BB
    PROSTAGLANDINS, 1986, 32 (06): : 791 - 802
12345